Bentham Science Logo

Letters in Drug Design & Discovery

Volume 16, 12 Issues, 2019
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access

Ranking and Category

  • 57th of 61 in

    Chemistry, Medicinal

Order Your Article Before Print

Contents

Letters in Drug Design & Discovery, Volume 3 - Number 10


The Chemokine CXCL10 as a Therapeutic Target in Animal Models of Neuroinflammatory Disease

, 3(10): 683 - 688

Rafael Gonzalez, Jenny L. Hardison, Janette Glaser, Michael T. Liu, Thomas E. Lane and Hans S. Keirstead


DOI: 10.2174/157018006778631839


Bridged Piperazines and Piperidines as CCR1 Antagonists with Oral Activity in Models of Arthritis and Multiple Sclerosis

, 3(10): 689 - 694

Laszlo Revesz, Birgit Bollbuck, Thomas Buhl, Janet Dawson, Roland Feifel, Richard Heng, Peter Hiestand, Helmut Sparrer, Achim Schlapbach, Rudolf Waelchli and Pius Loetscher


DOI: 10.2174/157018006778631866






Maintenance Treatment of Opioid Dependence and Patterns of Non-Prescribed Drug Use: Results of a 4-Year Trial

, 3(10): 731 - 740

Salvatore M. Giacomuzzi, Markus Ertl, Marion Pavlic, Kathrin Libiseller, Yvonne Riemer, Georg Kemmler, Haimo Rossler, Petra Grubwieser, Walter Rabl and H. Hinterhuber


DOI: 10.2174/157018006778631910




Gracilins G-I, Cytotoxic Bisnorditerpenes from Spongionella pulchella, and the Anti-Adhesive Properties of Gracilin B

, 3(10): 753 - 760

Ana Rueda, Alejandro Losada, Rogelio Fernandez, Carlos Cabanas, Luis F. Garcia- Fernandez, Fernando Reyes and Carmen Cuevas


DOI: 10.2174/157018006778631875





Editor-in-Chief

K. Kuca
University of Hradec Kralove
Hradec Kralove
Czech Republic

Biography View Full Editorial Board

Journal History

Letters in Drug Design & Discovery was introduced in 2004. Dr. Kamil Kuca serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Related Journals

Related eBooks

eBooks Catalog